Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 921–940 of 17,529 recalls

November 27, 2024· AvKARE

Recalled Item: Cinacalcet Tablets

The Issue: CGMP deviations: Presence of Nitrosamine Drug Substance Related

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 26, 2024· Curium US, LLC

Recalled Item: Kit for the Preparation of Technetium Tc 99m Sestamibi Injection

The Issue: Lack of Assurance of Sterility; Improper crimps on

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 25, 2024· Macleods Pharmaceuticals Ltd

Recalled Item: Olanzapine Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 22, 2024· Jubilant Draximage Inc., dba Jubilant Radiopharma

Recalled Item: Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection

The Issue: Failed Stability Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 22, 2024· Provepharm Inc.

Recalled Item: Dihydroergotamine Mesylate Injection

The Issue: Discoloration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 22, 2024· Apothecus Pharmaceutical Corp.

Recalled Item: VCF

The Issue: CGMP deviations: out of specifications for assay

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Javygtor (sapropterin dihydrochloride) Tablets 100mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
November 22, 2024· Generitech Corporation

Recalled Item: 10 Irregular Pigmentation

The Issue: CGMP Deviations: Inconsistency in the water systems

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine DR Capsules USP 60 mg

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets

The Issue: Labeling: Label Error on Declared Strength; Some cartons

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
November 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets

The Issue: Labeling: Label Error on Declared Strength; Some cartons

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
November 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablet

The Issue: Labeling: Label Error on Declared Strength; Some cartons

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund